1177 (1177) News
Follow 1177 (1177) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Sino Biopharmaceutical NDA accepted by China’s CDE for TQH2722 injection
Sino Biopharmaceutical Limited said China’s CDE has accepted its NDA for the TQH2722 injection.
REGULATION | Sep 16, 2026, 01:53 AM UTC
M
Sino Biopharmaceutical China CDE accepts NDA for TQB2102 injection
TradingView News reports that Sino Biopharmaceutical Limited (HKEX:1177) said China’s CDE accepted its new drug application for TQB2102 injection.
REGULATION | Sep 16, 2026, 01:22 AM UTC
M
Sino Biopharmaceutical unit to buy 5% in CT Tianqing
Sino Biopharmaceutical says its SBP Group will acquire a 5% equity interest in CT Tianqing for RMB4.48 billion at 19X LTM P/E.
MNA | Sep 11, 2026, 10:26 AM UTC
M
Sino Biopharmaceutical gets FDA IND approval for TQB6426 GPC3 ADC
Sino Biopharmaceutical Limited says the FDA has granted IND approval for TQB6426, a GPC3 ADC, for advanced malignant tumors.
REGULATION | Sep 03, 2026, 03:51 PM UTC